Segmental overgrowth and aneurysms due to mosaic PDGFRB p.(Tyr562Cys)

Jirat Chenbhanich1, Yan Hu2, Steven Hetts3

  • 1Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, California, USA.

Insights

Activating platelet-derived growth factor receptor β (PDGFRB) variants cause overgrowth and premature aging syndromes. This study highlights PDGFRB variants in patients with aneurysms, emphasizing the need for genetic testing and vascular imaging.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Developmental Biology

Background:

  • Activating variants in the platelet-derived growth factor receptor β (PDGFRB) gene are linked to Kosaki overgrowth syndrome, infantile myofibromatosis, and Penttinen premature aging syndrome.
  • A specific mosaic PDGFRB variant (c.1685A>G p.(Tyr562Cys)) has been associated with a phenotype including fusiform aneurysms.
  • Limited research exists on the vascular manifestations and mosaicism associated with PDGFRB variants.

Purpose of the Study:

  • To describe the clinical features of two patients with a recurrent mosaic PDGFRB p.(Tyr562Cys) variant.
  • To investigate the association between PDGFRB-activating variants and vascular phenotypes, particularly aneurysms.
  • To review existing literature for similar cases and consolidate knowledge on PDGFRB-related conditions.

Main Methods:

  • Next-generation sequencing-based genetic testing was used to identify the PDGFRB variant in two patients.
  • Clinical characteristics of the patients were documented.
  • A literature search was conducted to identify additional patients with aneurysms and phenotypes related to PDGFRB-activating variants.

Main Results:

  • Two patients with a recurrent mosaic PDGFRB p.(Tyr562Cys) variant were identified, with one presenting intracranial fusiform aneurysm.
  • A literature review revealed eight additional patients with aneurysms and phenotypes consistent with PDGFRB-activating variants.
  • Conditions associated with PDGFRB-activating variants share overlapping features such as overgrowth, premature aging of the skin, and vascular malformations including aneurysms.

Conclusions:

  • PDGFRB-activating variants are associated with a spectrum of conditions including overgrowth, premature aging, and progressive vascular malformations like aneurysms.
  • Germline and/or somatic PDGFRB gene testing is recommended for individuals presenting with related phenotypes.
  • Comprehensive vascular imaging (arterial tree and echocardiography) and follow-up imaging are crucial for managing these progressive conditions.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
124
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
139
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
148
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.7K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
79